This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2007 Sep 25;177(7):723-4.

doi: 10.1503/cmaj.071177. Epub 2007 Sep 6.

Diabetes drug pioglitazone (Actos): risk of fracture

Reza Heidarpour Meymeh¹, Eric Wooltorton

Affiliations

PMID: 17823139
PMCID: PMC1976649
DOI: 10.1503/cmaj.071177

Diabetes drug pioglitazone (Actos): risk of fracture

Reza Heidarpour Meymeh et al. CMAJ. 2007.

. 2007 Sep 25;177(7):723-4.

doi: 10.1503/cmaj.071177. Epub 2007 Sep 6.

Authors

Reza Heidarpour Meymeh¹, Eric Wooltorton

Affiliation

¹ Department of Family Medicine, University of Ottawa, Ottawa, Ont.

PMID: 17823139
PMCID: PMC1976649
DOI: 10.1503/cmaj.071177

No abstract available

PubMed Disclaimer

Similar articles

[Thiazolidinediones and skeletal health].
Meier C, Bodmer M, Meier CR, Kraenzlin ME. Meier C, et al. Rev Med Suisse. 2009 Jun 10;5(207):1309-10, 1312-3. Rev Med Suisse. 2009. PMID: 19626930 Review. French.
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
Aubert RE, Herrera V, Chen W, Haffner SM, Pendergrass M. Aubert RE, et al. Diabetes Obes Metab. 2010 Aug;12(8):716-21. doi: 10.1111/j.1463-1326.2010.01225.x. Diabetes Obes Metab. 2010. PMID: 20590749
Fracture risk is a class effect of glitazones.
Short R. Short R. BMJ. 2007 Mar 17;334(7593):551. doi: 10.1136/bmj.39154.373889.DB. BMJ. 2007. PMID: 17363794 Free PMC article. No abstract available.
Thiazolidinediones and fracture risk in patients with Type 2 diabetes.
Betteridge DJ. Betteridge DJ. Diabet Med. 2011 Jul;28(7):759-71. doi: 10.1111/j.1464-5491.2010.03187.x. Diabet Med. 2011. PMID: 21672000 Review.
Considering competing risks . . . Not all black and white.
Cauley JA, Ensrud KE. Cauley JA, et al. Arch Intern Med. 2008 Apr 28;168(8):793-5. doi: 10.1001/archinte.168.8.793. Arch Intern Med. 2008. PMID: 18443252 No abstract available.

See all similar articles

Cited by

Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis.
Billeter AT, Reiners B, Seide SE, Probst P, Kalkum E, Rupp C, Müller-Stich BP. Billeter AT, et al. Hepatobiliary Surg Nutr. 2022 Oct;11(5):696-708. doi: 10.21037/hbsn-21-5. Hepatobiliary Surg Nutr. 2022. PMID: 36268239 Free PMC article. Review.
Cellular and molecular effects of thiazolidinediones on bone cells: a review.
Mabilleau G, Chappard D, Baslé MF. Mabilleau G, et al. Int J Biochem Mol Biol. 2011;2(3):240-6. Epub 2011 Jun 20. Int J Biochem Mol Biol. 2011. PMID: 22003436 Free PMC article.
Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy.
Wang LX, Wang N, Xu QL, Yan W, Dong L, Li BL. Wang LX, et al. Biosci Rep. 2017 Mar 27;37(2):BSR20160544. doi: 10.1042/BSR20160544. Print 2017 Apr 28. Biosci Rep. 2017. PMID: 28153916 Free PMC article.
MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema.
Gregoire FM, Zhang F, Clarke HJ, Gustafson TA, Sears DD, Favelyukis S, Lenhard J, Rentzeperis D, Clemens LE, Mu Y, Lavan BE. Gregoire FM, et al. Mol Endocrinol. 2009 Jul;23(7):975-88. doi: 10.1210/me.2008-0473. Epub 2009 Apr 23. Mol Endocrinol. 2009. PMID: 19389808 Free PMC article.
Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism.
Mieczkowska A, Baslé MF, Chappard D, Mabilleau G. Mieczkowska A, et al. J Biol Chem. 2012 Jul 6;287(28):23517-26. doi: 10.1074/jbc.M111.324814. Epub 2012 May 16. J Biol Chem. 2012. PMID: 22593579 Free PMC article.

See all "Cited by" articles

References

1. Eli Lilly Canada Inc.; Health Canada. Increased incidence of fractures in female patients who received long-term treatment with ACTOS (pioglitazone hydrochloride) tablets for type 2 diabetes mellitus [letter]. Ottawa: Health Canada; 2007 Apr 18. Available: www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/2007/actos_hpc-cps_2... (accessed 2007 20 Aug).
1. Schwartz AV, Sellmeyer DE, Vittinghoff E, et al. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 2006;91:3349-54. Epub 2006 Apr 11. - PMC - PubMed
1. Brown JP, Josse RG, for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167(Suppl 10):1-34. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information